Table 3.
Strategy selection beyond the minimum required by site, setting, and opioid-related deaths per 100,000 population
| Study Sites | Setting | Deaths per 100 k a | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| KY | MA | NY | OH | Rural | Urban | <30.91 | >30.91 | ||
| Number of Communities | 8 | 8 | 8 | 9 | 15 | 18 | 16 | 17 | 33 |
| Strategies Selected, n | 217 | 133 | 156 | 112 | 271 | 347 | 276 | 342 | 618 |
| Strategies Selected beyond the minimum required b | 177 (81.6) | 93 (69.9) | 116 (74.4) | 67 (59.8) | 196 (72.3) | 257 (74.1) | 196 (71.0) | 257 (75.1) | 453 (73.3) |
| OEND b | 81 (45.8) | 33 (35.5) | 42 (36.2) | 29 (43.3) | 92 (46.9) | 93 (36.2) | 74 (37.8) | 111 (43.2) | 185 (40.8) |
| Active OEND c | 59 (72.8) | 18 (54.5) | 24 (57.1) | 25 (86.2) | 58 (63.0) | 68 (73.1) | 44 (59.5) | 82 (73.9) | 126 (68.1) |
| Optional OENDc | 22 (27.2) | 15 (45.5) | 18 (42.9) | 4 (13.8) | 34 (37.0) | 25 (26.9) | 30 (40.5) | 29 (26.1) | 59 (31.9) |
| MOUD b | 65 (36.7) | 31 (33.3) | 47 (40.5) | 16 (23.9) | 61 (31.1) | 98 (38.1) | 72 (36.7) | 87 (33.9) | 159 (35.1) |
| Expansiond | 15 (23.1) | 8 (25.8) | 18 (38.3) | 5 (31.3) | 18 (29.5) | 28 (28.6) | 25 (34.7) | 21 (24.1) | 46 (28.9) |
| Linkaged | 24 (36.9) | 13 (41.9) | 25 (53.2) | 9 (56.3) | 25 (41.0) | 46 (46.9) | 34 (47.2) | 37 (42.5) | 71 (44.7) |
| Engagement/retentiond | 26 (40.0) | 10 (32.3) | 4 (8.5) | 2 (12.5) | 18 (29.5) | 24 (24.5) | 13 (18.1) | 29 (33.3) | 42 (26.4) |
| Safer Prescribing/Dispensing b | 31 (17.5) | 29 (31.2) | 27 (23.3) | 22 (32.8) | 43 (21.9) | 66 (25.7) | 50 (25.5) | 59 (23.0) | 109 (24.1) |
| Required e | 23 (74.2) | 25 (86.2) | 13 (48.1) | 13 (59.1) | 30 (69.8) | 44 (66.7) | 30 (60.0) | 44 (74.6) | 74 (67.9) |
| Optional e | 8 (25.8) | 4 (13.8) | 14 (51.9) | 9 (40.9) | 13 (30.2) | 22 (33.3) | 20 (40.0) | 15 (25.4) | 35 (32.1) |
a
Each community’s death rate is the median of its 2018, 2019, 2020 yearly rates.
b
n (%) of total selected strategies that are beyond the minimum of 5 per community;
c
n (%) of strategies beyond the minimum that are OEND;
d
n (%) of strategies beyond the minimum that are MOUD;
e
n (%) of strategies beyond the minimum that are safer prescribing.